The risk for cancer among patients with schizoaffective disorders

Journal of Affective Disorders

Volumn 114, Issue 1-3, 2009, Pages 316-320

  Levav, Itzhak ^a   Kohn, Robert ^b   Barchana, Micha ^a   Lipshitz, Irena ^a   Pugachova, Inna ^a   Weizman, Abraham ^c   Grinshpoon, Alexander ^d  

^a MINISTRY OF HEALTH   (Israel)

^b BROWN UNIVERSITY   (United States)

^c TEL AVIV UNIVERSITY   (Israel)

^d Technion Medical School   (Israel)

Author keywords

Cancer; Epidemiology; Israel; Schizoaffective disorders

Indexed keywords

ARTICLE; BIPOLAR DISORDER; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CIGARETTE SMOKING; CONTROLLED STUDY; DATA BASE; FEMALE; HIGH RISK POPULATION; HUMAN; ISRAEL; JEW; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SEX DIFFERENCE;

AGE FACTORS; BIPOLAR DISORDER; COMORBIDITY; FEMALE; HUMANS; ISRAEL; JEWS; MALE; MIDDLE AGED; NEOPLASMS; PSYCHOTIC DISORDERS; RISK ASSESSMENT; SCHIZOPHRENIA; SEX FACTORS;

EID: 59649110866     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2008.06.010     Document Type: Article

References (25)

1. Barak Y., Achiron A., Mandel M., Mirecki I., and Aizenberg D. Reduced cancer incidence among patients with schizophrenia. Cancer 104 (2005) 2817-2821
2. Barchana M., Levav I., Lipshitz I., Pugachova I., Kohn R., Wezman A., and Grinshpoon A. Enhanced cancer risk among patients with bipolar disorder. J. Affect. Disord. 108 (2008) 43-48
3. Carney C.P., and Jones L.S. Medical comorbidity in women and men with bipolar disorders: a population-based controlled study Psychosom. Med. 68 (2006) 684-691
4. Catts V.S., and Catts S.V. Apoptosis and schizophrenia: is the tumour suppressor gene, p53, a candidate susceptibility gene?. Schizophr. Res. 41 (2000) 405-415
5. Catts V.S., Catts S.V., O'Toole B.I., and Frost A.D. Cancer incidence in patients with schizophrenia and their first-degree relatives - a meta-analysis. Acta Psych. Scand. 117 (2008) 323-336
6. Cheniaux E., Landeira-Fernandez J., Telles L.L., Lessa J.L., Dias A., Duncan T., and Versiani M. Does schizoaffective disorder really exist? A systematic review of the studies that compared schizoaffective disorder with schizophrenia or mood disorders. J. Affect. Disord. 106 (2008) 209-217
7. Dalton S.O., Laursen T.L., and Mellemkjaer L. Risk of cancer in parents of patients with schizophrenia. Am. J. Psychiatry 161 (2004) 903-908
8. Fishler Y., Barchana M., and Tischler T. Cancer registry training program for health information management professionals in Israel. J. Reg. Management 29 (2002) 78-85
9. Grinshpoon A., Barchana M., Ponizovsky A., Lipshitz I., Nahon D., Tal O., Weizman A., and Levav I. Cancer in schizophrenia: is the risk higher or lower?. Schizophr. Res. 73 (2005) 333-341
10. Israel Center for Disease Control. Trends in Morbidity and Mortality of Malignant Diseases in Israel, 1970-1995. Publication No.163 (1998), Israel Center for Disease Control, Jerusalem
11. Israel National Cancer Registry. Cancer in Israel - Annual Reports of the Israel National Cancer Registry, 1990, 1991, 1992, 1993, 1994, 1995, 1996, 1997, 1998, 1999, 2000 (2007), Ministry of Health, Jerusalem. http://www.health.gov.il/icr (www.health.gov.il/icr). Accessed in November
12. Kanarky C.G., Li Z., Nakai Y., Sei Y., and Weinberger D.R. Neuregulin-1 regulates cell adhesion via an ErbB2/phosphoinositide-3 kinase/Akt-dependent pathway: potential implications for schizophrenia and cancer. PLoS ONE. 26 (2007) e1369
13. Lawrence D., Holman C.D., Jablensky A.V., Threlfall T.J., and Fuller S.A. Excess cancer mortality in Western Australian psychiatric patients due to higher case fatality rates. Acta Psychiatr. Scand. 101 (2000) 382-388
14. Levav I., and Grinshpoon A. Mental health services in Israel. Int. Psychiatry 4 (2004) 10-14
15. Levav I., Lipshitz I., Nobikov I., Kohn R., Bar-Chana M., Ponizovsky A., and Werner H. Cancer risk among parents and siblings of patients with schizophrenia. Br. J. Psychiatry 190 (2007) 156-161
16. Lichtenberg P., Kaplan Z., Grinshpoon A., Feldman D., and Nahon D. The goals and limitations of Israel's psychiatric case register. Psychiatr. Serv. 50 (1999) 1043-1048
17. Lichtermann D., Ekelund J., and Pukkala E. Incidence of cancer among patients with schizophrenia and their relatives. Arch. Gen. Psychiatry 27 (2004) 187-195
18. Martin L.F., Hall M.H., Ross R.G., Zerbe G., Freedman R., and Olincy A. Physiology of schizophrenia, bipolar disorder, and schizoaffective disorder. Am J Psychiatry. 164 (2007) 1900-1906
19. Mental Health Services. Department of Information and Evaluation Ministry of Health Mental Health in Israel. Statistical Annual 2003 (2004), Ministry of Health, Jerusalem
20. Osborn D.P., Levy G., Nazareth I., Petersen I., Islam A., and King M.B. Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Research Database. Arch. Gen. Psychiatry 64 (2007) 242-249
21. Osby U., Brandt L., Correia N., Ekborn A., and Sparen P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch. Gen. Psychiatry 58 (2001) 844-850
22. In: Parkin D.M., Whelan S.L., and Ferlay J. (Eds). Cancer Incidence in Five Continents Volume VIII (2002), International Agency for Research on Cancer Lyon
23. Rabinowitz J., Slyuzberg M., and Ristner M. Changes in diagnosis in a 9-year national longitudinal sample. Compr. Psychiatry 35 (2000) 361-365
24. Weiser M., Kanyas K., and Malaspina D. Sensitivity of ICD-10 diagnosis of psychotic disorders in the Israeli National Hospitalization Registry compared with RDC diagnoses based on SADS-L. Compr. Psychiatry 46 (2005) 38-42
25. Health Organization. The ICD-10 Classification of Mental and Behavioral Disorders Clinical Descriptions and Diagnostic Guidelines (1992), World Health Organization, Geneva